USPTO serial 78865966
ARUP CONSULT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 26, 2008
- Examiner
- MICHOS, JOHN E
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with ARUP CONSULT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SALT LAKE CITY, UT, US
Associated Regional and University Pathologists, Inc.
Salt Lake City, UT, US
Other trademarks owned by Associated Regional and University Pathologists, Inc.
Associated Regional and University Pathologists, Inc.
Salt Lake City, UT, US
Other trademarks owned by Associated Regional and University Pathologists, Inc.
Associated Regional and University Pathologists, Inc.
Salt Lake City, UT, US
Other trademarks owned by Associated Regional and University Pathologists, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lester K. Essig
Lester K. Essig Ray Quinney & Nebeker36 South State StreetSuite 1400Salt Lake City, UT 84111Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Providing medical information online to pathologists, physicians and other healthcare practitioners over a global communications network, through handheld electronic devices and other means, with respect to tests, test results, test analysis, test trends, test effectiveness, test advisability, test selection, test ordering, test ordering management, test ordering procedures, test ordering efficiency, test ordering effectiveness, utilization management services, medical condition, health condition, and diagnosis in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, gene therapy, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microwave processing, microscopy, electron microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, health care, and child health care; and evaluating data, identifying trends, designing reports, reporting, delivering reports and making recommendations with respect to test results, test analysis, test trends, test efficiency, test effectiveness, test advisability, test selection, test ordering, test ordering management, test ordering procedures, test ordering efficiency, test ordering effectiveness, utilization management services, medical condition, health condition, and diagnosis in the fields of pathology, clinical pathology, anatomic pathology, histopathology, histology, infectious diseases, disease pathology, infectious disease pathology, staining analysis, virology, hematopathology, hematology, proteomics, hemostasis, thrombosis, flow analysis, flow cytometry, capillary electrophoresis, genetics, molecular genetics, biochemical genetics, genetic diseases, gene identification, gene sequencing, nucleotide sequencing, genotypic identification, phenotypic identification, probe synthesis, gene therapy, mass spectrometry, tandem mass spectrometry, molecular testing, molecular diagnostics, molecular evaluation, cytopathology, cytology, cytogenetics, oncology, tumor detection, tumor markers, tumor diagnostics, mutation detection, mutation analysis, morphologic change, immunopathology, immunology, immunohematology, immunohistochemical staining, immunofluorescence, autoimmune disorders, microbiology, serology, microbial serology, endocrinology, clinical chemistry, toxicology, clinical toxicology, toxins, pharmacogenomics, therapeutic drugs, transplantation pathology, surgical pathology, autopsy pathology, metabolics, metabolic status, nutritional status, microwave processing, microscopy, electron microscopy, core lab testing, engineering analysis, laboratory automation, medical informatics, health care, and child health care | ACTIVE | Sep 29, 2006 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ARUP LABORATORIES, INC.
- Other trademarks owned by Associated Regional and University Pathologists, Inc.
- Other trademarks owned by Associated Regional and University Pathologists, Inc.
- Other trademarks owned by Associated Regional and University Pathologists, Inc.
- Other trademarks in Class 044
- Similar marks named ARUP CONSULT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 28, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 28, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2024 | CCON | COUNTERCLAIM OPP. NO. 999999 | — |
| Sep 1, 2018 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Sep 1, 2018 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Sep 1, 2018 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Sep 1, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 24, 2018 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Sep 11, 2014 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED | — |
| Sep 11, 2014 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 11, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 27, 2014 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Aug 27, 2014 | PAPER RECEIVED | — | |
| Mar 20, 2013 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 26, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2008 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Jul 21, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jul 21, 2008 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 14, 2008 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 29, 2008 | PAPER RECEIVED | — | |
| May 27, 2008 | IUAF | USE AMENDMENT FILED | — |
| Nov 27, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 4, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 27, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 25, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 5, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 2, 2007 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 7, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 7, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 27, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2007 | ALIE | ASSIGNED TO LIE | — |
| Mar 28, 2007 | PAPER RECEIVED | — | |
| Sep 26, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2006 | NWAP | NEW APPLICATION ENTERED | — |